Hostname: page-component-89b8bd64d-n8gtw Total loading time: 0 Render date: 2026-05-06T20:10:13.943Z Has data issue: false hasContentIssue false

Nutritional level and energetic source are determinants of elevated circulatory lipohydroperoxide concentration

Published online by Cambridge University Press:  01 June 2008

B. Löhrke*
Affiliation:
FBN-Dummerstorf, Wilhelm-Stahl-Allee-2, D-18196-Dummerstorf, Germany
M. Derno
Affiliation:
FBN-Dummerstorf, Wilhelm-Stahl-Allee-2, D-18196-Dummerstorf, Germany
H. Hammon
Affiliation:
FBN-Dummerstorf, Wilhelm-Stahl-Allee-2, D-18196-Dummerstorf, Germany
C. Metges
Affiliation:
FBN-Dummerstorf, Wilhelm-Stahl-Allee-2, D-18196-Dummerstorf, Germany
J. Melcher
Affiliation:
FBN-Dummerstorf, Wilhelm-Stahl-Allee-2, D-18196-Dummerstorf, Germany
T. Viergutz
Affiliation:
FBN-Dummerstorf, Wilhelm-Stahl-Allee-2, D-18196-Dummerstorf, Germany
W. Jentsch
Affiliation:
FBN-Dummerstorf, Wilhelm-Stahl-Allee-2, D-18196-Dummerstorf, Germany
H. Zühlke
Affiliation:
FBN-Dummerstorf, Wilhelm-Stahl-Allee-2, D-18196-Dummerstorf, Germany
*
*Corresponding author: Dr Berthold Löhrke, fax +49 38208 68 752, email viergutz@fbn-dummerstorf.de
Rights & Permissions [Opens in a new window]

Abstract

Dietary energetic impact on oxidative stress is incompletely understood. Therefore, effects of diets on oxidative stress were studied using a crossover block design. In Expt 1, intake of metabolizable energy (ME) was restricted or ad libitum. In Expt 2, isoenergetic and isonitrogenic diets were fed, replacing carbohydrate energy by energy of fatty acids. Circulatory lipohydroperoxides (LOOH), markers of acute oxidative stress, were expressed absolutely and in terms of cholesterol or TAG levels. In Expt 1, plasma (jugularis vein) LOOH was assayed in combination with whole-body oxidative metabolism using gas exchange and heart rate (HR) during feeding periods and at rest. In Expt 2, LOOH was assayed in plasma from portal and a large udder vein and a mesenteric artery. In Expt 1, intake increased VO2, HR and LOOH following overnight fast with higher values (P < 0·05) when feeding ME ad libitum. Intake of ME ad libitum (3 weeks) increased cardiac protein of cytochrome oxidase and endothelial-type nitric oxide synthase (P < 0·05), indicating adaptation of the heart to higher activity. Transient HR responses evoked by an antidiabetic drug (levcromakalim) revealed a linear positive correlation with relative LOOH (r2 0·79), supporting the relationship between oxidative metabolic rate and lipoperoxidation. Evidence for exogenous lipids as LOOH source provided the vessel-specific rise in LOOH through replacing carbohydrate ME by lipid ME (Expt 2). Thus, dietary energy level and energetic source are important for circulatory LOOH with a role of vascular activity in production of oxidant.

Information

Type
Full Papers
Copyright
Copyright © The Authors 2008
Figure 0

Table 1 The balanced block design*

Figure 1

Table 2 Diet composition (Expt 1)

Figure 2

Table 3 Composition of starch- and fat-based diets (Expt 2)

Figure 3

Table 4 Ingredients of starch- and fat-based diets (Expt 2)

Figure 4

Fig. 1 Circulating lipohydroperoxide (LOOH) levels in response to different intakes of metabolizable energy (ME). (A), Temporal concentrations of plasma LOOH and those relative to total cholesterol (B), LDL cholesterol (C) and TAG (D) levels. For clarity, cholesterol values are multiplied by 10− 3. Values are means with standard deviations depicted by vertical bars (eight repetitions on four consecutive days, thirty-two samples per time-point), regarding ad libitum ME intake () and restricted ME intake (□). Blood was drawn before and after food intake in the morning and afternoon as indicated. Plasma concentrations of LOOH, TAG and cholesterol were determined as described in the Experimental methods section. a–d Mean values with unlike superscript letters were significantly different (ANOVA, (A) P = 0·0006, (B) P = 0·0008, (C) P = 0·0009, (D) P = 0·0005; Newman–Keuls procedure, P < 0·05).

Figure 5

Fig. 2 Temporal course of intake-induced changes in gas exchange and heart rate. Heart rate, VO2 and production of CO2 were continuously measured in respiration chambers. (A), Values are least square means (LSM), with their standard errors depicted by vertical bars, of the heart rate (beats per minute (bpm)) in periods corresponding with overnight fast (00.00–06.00 hours), morning meal intake (08.00–09.00 hours), intermediate rest (11.00–13.00 hours) and afternoon meal intake (14.00–15.00 hours). Mean values were significantly different between intake levels: ANOVA, *P = 0·0003; Newman–Keuls procedure, *P < 0·05 (n 8). a,b Temporal mean values with unlike superscript letters were significantly different (ANOVA, P = 0·0005; Newman-Keuls procedure, P < 0·05). VO2 data (B) and RER (C) are indicated in periods corresponding with overnight fasting (00.00–06.00 hours, basal) and ad libitum and restricted food intake. Food was offered in the morning and in the afternoon as indicated. Values are LSM with their standard errors depicted by vertical bars (n 8). Values were significantly different between intake levels: *P < 0·05, Newman–Keuls procedure (n 8). a,b,c Temporal mean values with unlike superscript letters were significantly different (ANOVA, P = 0·001; Newman–Keuls procedure, P < 0·05).

Figure 6

Fig. 3 Drug-evoked correlation between plasma lipohydroperoxide (LOOH) level and heart rate. (A), Values are least square means (LSM), with their standard errors depicted by vertical bars, of the heart rate (beats per minute (bpm)), using records in periods as indicated to demonstrate instant responses to treatment (5 min periods), temporal attenuation (20–40 min period) and modified responses to intake of a meal providing metabolizable energy ad libitum. Basal LSM refers to the period before treatment ( − 60 to 0 min). Levcromakalim (Lev, 80 nmol/kg, n 8) was administered as an opener, glibenclamide (Gli, 400 nmol/kg 2 min before Lev, n 4) as an inhibitor of ATP/ADP-regulated potassium channels. Mean values were significantly different between treatments with Lev and the carrier: ANOVA, P = 0·002; Newman–Keuls procedure, P < 0·05. a,b,c Temporal LSM of Lev values with unlike superscript letters were significantly different (ANOVA, P = 0·0003; Newman–Keuls procedure, P < 0·05). (B), Circulatory LOOH levels relative to plasma cholesterol concentration ( × 10− 3) at bleeding times as indicated. Values are means with their standard errors depicted by vertical bars (n 8). Mean values were significantly different between treatments with Lev and the carrier: ANOVA, P = 0·002; Newman–Keuls procedure, P < 0·05. (C), Plot of heart rate (HR) values from (A) v. corresponding LOOH values from (B) with r2 0·79 and P = 0·04 for the slope of the regression function.

Figure 7

Fig. 4 Dietary effects on the relative abundance of cytochrome oxidase, Cu/Zn superoxide dismutase (SOD), nitric oxide synthase (eNOS) and 3-nitrotyrosine in cardiomyocytes. (A), Representative flow cytometric result obtained by plotting the number of fluorescence-positive cells with subunit IV of cytochrome oxidase as the antigen against fluorescence intensity (FI) per cell (flow cytometric channel number), gating β-actin-positive cells (cardiomyocytes). A shift of FI toward higher values parallels increase in immunoreactive protein per cell. Single cells were prepared by collagenase digestion of heart ventricle specimens. Peak I represents a control, replacing specific antibodies by unspecific ones; peak II denotes incubation with specific Ig followed by fluorescent antispecies Ig in both reactions. (B), Values are means, with their standard errors depicted by vertical bars (n 8), expressed by the ratio between ad libitum and restricted metabolizable energy (ME) intake. Mean values show significant increase in immunoreactive protein with ad libitum ME intake (Dunnett's procedure): *P < 0·05.

Figure 8

Fig. 5 Diet-induced vessel-specific changes in lipohydroperoxide (LOOH) level and the ratios between LOOH and compartmentalized cholesterol. Plasma from mesenteric artery (Ma), portal (Pv) and a large udder vein (Uv) was obtained following feeding isoenergetic and isonitrogenic diets with starch (□) or protected palmitic and oleic acids () as the major energy source. LOOH were determined in organic phase plasma extracts as described in the Experimental methods section. For clarity, (B), (C) and (D) denote ratios between LOOH and cholesterol concentration × 10− 3. Values are means with standard deviations depicted by vertical bars (Ma and Pv, n 12; Uv, n 8). a,b,c Mean values with unlike superscript letters were significantly different (ANOVA, (A) P = 0·0004, (B) P = 0·001, (C) P = 0·009, (D) P = 0·01; Dunnett's or Dunn's procedure, P < 0·05).